Jul 20, 2009 - Pharmalucence, Inc., a leading supplier of radiopharmaceutical products, announced today that it received approval from the U. S. FDA Office of Generic Drugs for its ANDA to manufacture and market its Kit for the Preparation of Technetium Tc-99m Sestamibi Injection.
The details can be read here.
No comments:
Post a Comment